Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263211 · ClinicalTrials.gov registry record · Phase 2
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00263211: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.
NCT00263211 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 48 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00263211, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer.
Primary Outcome
Measured by number of patients who have detectable circulating tumor cells
Interventions
- DRUG Aspirin
- DRUG Plavix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Why NCT00263211 stopped before completion
NCT00263211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT00263211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00263211 about?
NCT00263211 is a clinical study titled "A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients". The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer.
What is the current status of trial NCT00263211?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2006-01. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00263211?
The interventions under investigation include: Aspirin (DRUG), Plavix (DRUG).
Who is sponsoring clinical trial NCT00263211?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00263211's enrollment target sits among peer trials
48 1265th of 2000 higher than 718 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia